Skip to content
AnalystLens

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2022

Filing Date
Filed February 24, 2023
Period End
December 31, 2022
Security
UNH
One revenue dollarkept$0.06
In the record · 2016–202610-K1110-Q328-K173

UNH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 173 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Feb ’22Feb ’22
  2. Leadership change8-K · Mar ’26Mar ’26

Summary

Summary of the 10-K filed February 24, 2023. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group Inc. (UNH) demonstrated robust financial performance in 2022, with consolidated revenues increasing by 13% to $324.2 billiona.

This growth was driven by strong performance across both its UnitedHealthcare and Optum segments, with Optum revenues growing 17% and UnitedHealthcare revenues growing 12%. The company also saw a significant increase in earnings from operations, up 19%, and diluted earnings per share rose 17% to $21.18b. The company continues to expand its reach, serving nearly 1.1 million more people through its UnitedHealthcare offerings, particularly in community-based and senior care.

The Optum segment, comprising Optum Health, Optum Insight, and Optum Rx, showed substantial growth, reflecting its expanding role in care delivery, data analytics, and pharmacy services. Cash flow from operations remained strong at $26.2 billionc, and the company maintained a healthy return on equity of 27.2%, indicating efficient use of shareholder capital.

Key Highlights

  1. Consolidated revenues grew 13% to $324.2 billion in 2022, driven by a 17% increase in Optum revenues and a 12% increase in UnitedHealthcare revenues.
  2. Diluted earnings per share increased 17% to $21.18, reflecting strong operational performance across the company.
  3. UnitedHealthcare expanded its member base by approximately 1.1 million people, with notable growth in Medicare Advantage and Medicaid offerings.
  4. Optum Health saw revenue growth of 32%, driven by value-based care arrangements and business combinations, serving approximately 102 million people.
  5. Optum Rx managed $124 billion in pharmaceutical spending and fulfilled 1.44 billion adjusted scripts, showing growth in volume and services.
  6. Cash flow from operations was robust at $26.2 billion, providing significant financial flexibility.
  7. Return on equity stood at a strong 27.2%, indicating effective capital utilization.

Follow one dollar

Of each $1.00 of revenue in FY2022, UnitedHealth Group Inc kept $0.06.

  1. Revenue$324.16B100.0%
  2. Cost of revenue−$33.70B10.4%
  3. Gross profit$290.46B89.6%
  4. Operating costs−$262.02B80.8%
  5. Operating income$28.43B8.8%
  6. Interest, other & tax−$8.31B2.6%
  7. Net income$20.12B6.2%
Computed from 10-KFY2022filed February 24, 2023Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2022 revenue went

$324.16B
  • Other operating costs: $214.24B, 66% of revenue
  • SG&A: $47.78B, 15% of revenue
  • Net income: $20.12B, 6.2% of revenue
  • Cost of revenue: $33.70B, 10% of revenue
  • Interest, other & tax: $8.31B, 2.6% of revenue

Kept 6.2% as net income

Full revenue history →

Financial Statements

FY2022 against FY2021

Line itemFY2022FY2021Change
Revenue$324.16B$287.60B+12.7%
Cost of Revenue$33.70B$31.03B+8.6%
Gross Profit$290.46B$256.56B+13.2%
SG&A Expenses$47.78B$42.58B+12.2%
Operating Expenses$295.73B$263.63B+12.2%
Operating Income$28.43B$23.97B+18.6%
Interest Expense$2.09B$1.66B+26.0%
Net Income$20.12B$17.29B+16.4%
EPS (Basic)$21.47$18.33+17.1%
EPS (Diluted)$21.18$18.08+17.1%
Shares Outstanding (Basic)937.00M943.00M−0.6%
Shares Outstanding (Diluted)950.00M956.00M−0.6%

Frequently Asked Questions

  1. What were the main drivers of UnitedHealth Group's revenue growth in 2022?

    Revenue growth in 2022 was primarily driven by an increase in the number of people served across both Medicare Advantage and Medicaid programs within UnitedHealthcare, alongside the continued growth of Optum's various businesses, particularly Optum Health and Optum Rx. Pricing trends and expansion of services also contributed significantly.

  2. How is the company managing medical costs, and what is the medical care ratio (MCR)?

    UnitedHealth Group manages medical costs through strategies like underwriting, product design, provider contract negotiations, and care management programs. The medical costs increased due to the growth in people served. The Medical Care Ratio (MCR) for 2022 was 82.0%, a slight decrease from 82.6% in 2021, influenced by the ongoing effects of COVID-19 and changes in prior year favorable development and business mix.

  3. What is the significance of the acquisition of Change Healthcare?

    The acquisition of Change Healthcare, completed in October 2022 for $13.9 billion, is intended to connect and simplify core clinical, administrative, and payment processes across the healthcare system. Change Healthcare's technologies and capabilities are expected to enhance workflow and transactional connectivity, aiming to create a more efficient and integrated health care ecosystem for providers and payers.

  4. What are the key risks and uncertainties facing UnitedHealth Group?

    Key risks include the inability to accurately estimate, price for, and manage medical costs, which could impact profitability on risk-based products. Other significant risks involve maintaining data integrity and system availability, potential cyber-attacks and data security breaches, intense competition within the healthcare market, challenges in managing relationships with healthcare providers, and navigating complex and evolving regulatory environments at both federal and state levels, particularly concerning Medicare and Medicaid funding.